164 related articles for article (PubMed ID: 12176255)
1. Oxaliplatin loaded PLAGA microspheres: design of specific release profiles.
Lagarce F; Cruaud O; Deuschel C; Bayssas M; Griffon-Etienne G; Benoit J
Int J Pharm; 2002 Aug; 242(1-2):243-6. PubMed ID: 12176255
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
Chen W; Lu DR
J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice.
Li JQ; Wang SL; Xu F; Liu ZY; Li R
Anticancer Drugs; 2010 Jul; 21(6):600-8. PubMed ID: 20527722
[TBL] [Abstract][Full Text] [Related]
5. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
[TBL] [Abstract][Full Text] [Related]
7. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
8. PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique.
Bao W; Zhou J; Luo J; Wu D
J Microencapsul; 2006 Aug; 23(5):471-9. PubMed ID: 16980270
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres.
Blanco-Príeto MJ; Besseghir K; Zerbe O; Andris D; Orsolini P; Heimgartner F; Merkle HP; Gander B
J Control Release; 2000 Jun; 67(1):19-28. PubMed ID: 10773325
[TBL] [Abstract][Full Text] [Related]
10. Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release.
Wu J; Zhao X; Yeung KW; To MK
Curr Drug Deliv; 2016; 13(5):720-9. PubMed ID: 26638974
[TBL] [Abstract][Full Text] [Related]
11. Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
Schaefer MJ; Singh J
Biomaterials; 2002 Aug; 23(16):3465-71. PubMed ID: 12099290
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
15. [Effect of preparation technique on in vitro release mechanism of huperzine A microspheres].
Fu XD; Gao YL; Ping QN
Yao Xue Xue Bao; 2006 Jul; 41(7):589-94. PubMed ID: 17007348
[TBL] [Abstract][Full Text] [Related]
16. Jet milling--a new technique for microparticle preparation.
Nykamp G; Carstensen U; Müller BW
Int J Pharm; 2002 Aug; 242(1-2):79-86. PubMed ID: 12176228
[TBL] [Abstract][Full Text] [Related]
17. Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
Schaefer MJ; Singh J
AAPS PharmSciTech; 2000 Nov; 1(4):E32. PubMed ID: 14727897
[TBL] [Abstract][Full Text] [Related]
18. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
19. Cephradin-plaga microspheres for sustained delivery to cattle.
Ustariz-Peyret C; Coudane J; Vert M; Kaltsatos V; Boisramé B
J Microencapsul; 1999; 16(2):181-94. PubMed ID: 10080112
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
